Skip to main content
Erschienen in: Tumor Biology 10/2016

22.07.2016 | Review

Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures

verfasst von: Olga Golubnitschaja, Manuel Debald, Kristina Yeghiazaryan, Walther Kuhn, Martin Pešta, Vincenzo Costigliola, Godfrey Grech

Erschienen in: Tumor Biology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

Rapidly increasing incidence of breast cancer is a new social challenge resulting from a spectrum of internal and external risk factors which appear to be well accepted as an attribute of the early twenty-first century, being, however, new for female sub-populations compared to the past. These include altered socio-economical conditions such as occupational exposure, rotating shift work, specific environmental factors (increased pollution and environmental toxicity, altered dietary habits, quality and composition of meal) as well as consequently shifted and/or adapted physiologic factors such as lower age at menarche, late age of first full-term pregnancy, if any, shorter periods of breastfeeding and later menopause. Consolidated expert statements suggest that over 50 % of all breast cancer cases may be potentially prevented by risk reduction strategy such as regulation of modifiable risk factors. Currently available risk assessment models may estimate potential breast cancer predisposition, in general; however, they are not able to predict the disease manifestation individually. Further, current deficits in risk assessment and effective breast cancer prevention have been recently investigated and summarised as follows: gaps in risk estimation, preventive therapy, lifestyle prevention, understanding of the biology of breast cancer risk and implementation of known preventive measures. This paper overviews the most relevant risk factors, provides recommendations for improved risk assessment and proposes an extended questionnaire for effective preventive measures.
Literatur
1.
Zurück zum Zitat Golubnitschaja O, Yeghiazaryan K, Costigliola V, Trog D, Braun M, Debald M, et al. Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon? EPMA J. 2013;4(1):6.PubMedPubMedCentralCrossRef Golubnitschaja O, Yeghiazaryan K, Costigliola V, Trog D, Braun M, Debald M, et al. Risk assessment, disease prevention and personalised treatments in breast cancer: is clinically qualified integrative approach in the horizon? EPMA J. 2013;4(1):6.PubMedPubMedCentralCrossRef
2.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.PubMedCrossRef Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.PubMedCrossRef
3.
Zurück zum Zitat Leung GM, Thach TQ, Lam T-H, Hedley AJ, Foo W, Fielding R, et al. Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. Br J Cancer. 2002;87(9):982–8.PubMedPubMedCentralCrossRef Leung GM, Thach TQ, Lam T-H, Hedley AJ, Foo W, Fielding R, et al. Trends in breast cancer incidence in Hong Kong between 1973 and 1999: an age-period-cohort analysis. Br J Cancer. 2002;87(9):982–8.PubMedPubMedCentralCrossRef
4.
Zurück zum Zitat Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol. 2005;34(2):405–12.PubMedCrossRef Althuis MD, Dozier JM, Anderson WF, Devesa SS, Brinton LA. Global trends in breast cancer incidence and mortality 1973-1997. Int J Epidemiol. 2005;34(2):405–12.PubMedCrossRef
5.
Zurück zum Zitat Jung YS, Na KY, Kim KS, Ahn S-H, Lee SJ, Lee S-J, et al. Nation-wide Korean breast cancer data from 2008 using the breast cancer registration program. J Breast Cancer. 2011;14(3):229–36.PubMedPubMedCentralCrossRef Jung YS, Na KY, Kim KS, Ahn S-H, Lee SJ, Lee S-J, et al. Nation-wide Korean breast cancer data from 2008 using the breast cancer registration program. J Breast Cancer. 2011;14(3):229–36.PubMedPubMedCentralCrossRef
6.
Zurück zum Zitat Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, et al. Risk determination and prevention of breast cancer. Breast Cancer Res. 2014;16(5):446.PubMedPubMedCentralCrossRef Howell A, Anderson AS, Clarke RB, Duffy SW, Evans DG, Garcia-Closas M, et al. Risk determination and prevention of breast cancer. Breast Cancer Res. 2014;16(5):446.PubMedPubMedCentralCrossRef
7.
Zurück zum Zitat Girotra S, Yeghiazaryan K, Golubnitschaja O. Potential biomarker panels in overall breast cancer management: advancements by multilevel diagnostics. Pers Med. 2016; in press. Girotra S, Yeghiazaryan K, Golubnitschaja O. Potential biomarker panels in overall breast cancer management: advancements by multilevel diagnostics. Pers Med. 2016; in press.
8.
Zurück zum Zitat Lemke HU, Golubnitschaja O. Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within ‘horizon 2020’. EPMA J. 2014;5(1):8.PubMedPubMedCentralCrossRef Lemke HU, Golubnitschaja O. Towards personal health care with model-guided medicine: long-term PPPM-related strategies and realisation opportunities within ‘horizon 2020’. EPMA J. 2014;5(1):8.PubMedPubMedCentralCrossRef
9.
Zurück zum Zitat Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomark Prev. 1995;4(5):567–71. Colditz GA, Frazier AL. Models of breast cancer show that risk is set by events of early life: prevention efforts must shift focus. Cancer Epidemiol Biomark Prev. 1995;4(5):567–71.
10.
Zurück zum Zitat Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ, et al. Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst. 2013;105(20):1571–8.PubMedPubMedCentralCrossRef Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ, et al. Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst. 2013;105(20):1571–8.PubMedPubMedCentralCrossRef
11.
Zurück zum Zitat Johansson H, Bonanni B, Gandini S, Guerrieri-Gonzaga A, Cazzaniga M, Serrano D, et al. Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide. Breast Cancer Res Treat. 2013;142(3):569–78.PubMedCrossRef Johansson H, Bonanni B, Gandini S, Guerrieri-Gonzaga A, Cazzaniga M, Serrano D, et al. Circulating hormones and breast cancer risk in premenopausal women: a randomized trial of low-dose tamoxifen and fenretinide. Breast Cancer Res Treat. 2013;142(3):569–78.PubMedCrossRef
12.
Zurück zum Zitat Komm BS, Mirkin S. An overview of current and emerging SERMs. J Steroid Biochem Mol Biol. 2014;143:207–22.PubMedCrossRef Komm BS, Mirkin S. An overview of current and emerging SERMs. J Steroid Biochem Mol Biol. 2014;143:207–22.PubMedCrossRef
13.
Zurück zum Zitat Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187–95.CrossRef Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and breastfeeding: collaborative reanalysis of individual data from 47 epidemiological studies in 30 countries, including 50302 women with breast cancer and 96973 women without the disease. Lancet. 2002;360(9328):187–95.CrossRef
14.
Zurück zum Zitat Ballard-Barbash R, Hunsberger S, Alciati MH, Blair SN, Goodwin PJ, McTiernan A, et al. Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst. 2009;101(9):630–43.PubMedPubMedCentralCrossRef Ballard-Barbash R, Hunsberger S, Alciati MH, Blair SN, Goodwin PJ, McTiernan A, et al. Physical activity, weight control, and breast cancer risk and survival: clinical trial rationale and design considerations. J Natl Cancer Inst. 2009;101(9):630–43.PubMedPubMedCentralCrossRef
15.
16.
Zurück zum Zitat Zeng H, Irwin ML, Lu L, Risch H, Mayne S, Mu L, et al. Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1. Breast Cancer Res Treat. 2012;133(1):127–35.PubMedCrossRef Zeng H, Irwin ML, Lu L, Risch H, Mayne S, Mu L, et al. Physical activity and breast cancer survival: an epigenetic link through reduced methylation of a tumor suppressor gene L3MBTL1. Breast Cancer Res Treat. 2012;133(1):127–35.PubMedCrossRef
17.
Zurück zum Zitat Rubinstein WS, O’neill SM, Rothrock N, Starzyk EJ, Beaumont JL, Acheson LS, et al. Components of family history associated with women’s disease perceptions for cancer: a report from the Family Healthware™ Impact Trial. Genitourin Med. 2011;13(1):52–62.CrossRef Rubinstein WS, O’neill SM, Rothrock N, Starzyk EJ, Beaumont JL, Acheson LS, et al. Components of family history associated with women’s disease perceptions for cancer: a report from the Family Healthware™ Impact Trial. Genitourin Med. 2011;13(1):52–62.CrossRef
18.
Zurück zum Zitat Randall TC, Armstrong K. Health care disparities in hereditary ovarian cancer: are we reaching the underserved population? Curr Treat Options in Oncol. 2016;17(8):39.CrossRef Randall TC, Armstrong K. Health care disparities in hereditary ovarian cancer: are we reaching the underserved population? Curr Treat Options in Oncol. 2016;17(8):39.CrossRef
19.
Zurück zum Zitat Alford SH, Leadbetter S, Rodriguez JL, Hawkins NA, Scholl LE, Peipins LA. Cancer screening among a population-based sample of insured women. Prev Med Rep. 2015;2:15–20.PubMedCrossRef Alford SH, Leadbetter S, Rodriguez JL, Hawkins NA, Scholl LE, Peipins LA. Cancer screening among a population-based sample of insured women. Prev Med Rep. 2015;2:15–20.PubMedCrossRef
21.
Zurück zum Zitat Heikkilä K, Nyberg ST, Theorell T, Fransson EI, Alfredsson L, Bjorner JB, et al. Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116,000 European men and women. BMJ. 2013;346:f165.PubMedPubMedCentralCrossRef Heikkilä K, Nyberg ST, Theorell T, Fransson EI, Alfredsson L, Bjorner JB, et al. Work stress and risk of cancer: meta-analysis of 5700 incident cancer events in 116,000 European men and women. BMJ. 2013;346:f165.PubMedPubMedCentralCrossRef
22.
Zurück zum Zitat Fazzo L, Carere M, Tisano F, Bruno C, Cernigliaro A, Cicero MR, et al. Cancer incidence in Priolo, Sicily: a spatial approach for estimation of industrial air pollution impact. Geospat Health. 2016;11(1):320.PubMedCrossRef Fazzo L, Carere M, Tisano F, Bruno C, Cernigliaro A, Cicero MR, et al. Cancer incidence in Priolo, Sicily: a spatial approach for estimation of industrial air pollution impact. Geospat Health. 2016;11(1):320.PubMedCrossRef
23.
Zurück zum Zitat Zimeri AM, Robb SW, Hassan SM, Hire RR, Davis MB. Assessing heavy metal and PCB exposure from tap water by measuring levels in plasma from sporadic breast cancer patients, a pilot study. Int J Environ Res Public Health. 2015;12(12):15683–91.PubMedPubMedCentralCrossRef Zimeri AM, Robb SW, Hassan SM, Hire RR, Davis MB. Assessing heavy metal and PCB exposure from tap water by measuring levels in plasma from sporadic breast cancer patients, a pilot study. Int J Environ Res Public Health. 2015;12(12):15683–91.PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Alatise OI, Schrauzer GN. Lead exposure: a contributing cause of the current breast cancer epidemic in Nigerian women. Biol Trace Elem Res. 2010;136(2):127–39.PubMedPubMedCentralCrossRef Alatise OI, Schrauzer GN. Lead exposure: a contributing cause of the current breast cancer epidemic in Nigerian women. Biol Trace Elem Res. 2010;136(2):127–39.PubMedPubMedCentralCrossRef
25.
Zurück zum Zitat Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108(11):2205–40.PubMedPubMedCentralCrossRef Marmot MG, Altman DG, Cameron DA, Dewar JA, Thompson SG, Wilcox M. The benefits and harms of breast cancer screening: an independent review. Br J Cancer. 2013;108(11):2205–40.PubMedPubMedCentralCrossRef
26.
Zurück zum Zitat Little MP, McElvenny DM. Male breast cancer incidence and mortality risk in the Japanese atomic bomb survivors—differences in excess relative and absolute risk from female breast cancer. Environ Health Perspect. 2016. doi:10.1289/EHP151. PubMed Little MP, McElvenny DM. Male breast cancer incidence and mortality risk in the Japanese atomic bomb survivors—differences in excess relative and absolute risk from female breast cancer. Environ Health Perspect. 2016. doi:10.​1289/​EHP151.​ PubMed
27.
Zurück zum Zitat White AJ, Bradshaw PT, Herring AH, Teitelbaum SL, Beyea J, Stellman SD, et al. Exposure to multiple sources of polycyclic aromatic hydrocarbons and breast cancer incidence. Environ Int. 2016;89–90:185–92.PubMedCrossRef White AJ, Bradshaw PT, Herring AH, Teitelbaum SL, Beyea J, Stellman SD, et al. Exposure to multiple sources of polycyclic aromatic hydrocarbons and breast cancer incidence. Environ Int. 2016;89–90:185–92.PubMedCrossRef
29.
Zurück zum Zitat Kotepui M. Diet and risk of breast cancer. Contemp Oncol Pozn Pol. 2016;20(1):13–9. Kotepui M. Diet and risk of breast cancer. Contemp Oncol Pozn Pol. 2016;20(1):13–9.
30.
Zurück zum Zitat Seitz HK, Pelucchi C, Bagnardi V, La Vecchia C. Epidemiology and pathophysiology of alcohol and breast cancer: update 2012. Alcohol Alcohol. 2012;47(3):204–12.PubMedCrossRef Seitz HK, Pelucchi C, Bagnardi V, La Vecchia C. Epidemiology and pathophysiology of alcohol and breast cancer: update 2012. Alcohol Alcohol. 2012;47(3):204–12.PubMedCrossRef
31.
Zurück zum Zitat Cebioglu M, Schild H, Golubnitschaja O. Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures. EPMA J. 2010;1(1):130–7.PubMedPubMedCentralCrossRef Cebioglu M, Schild H, Golubnitschaja O. Cancer predisposition in diabetics: risk factors considered for predictive diagnostics and targeted preventive measures. EPMA J. 2010;1(1):130–7.PubMedPubMedCentralCrossRef
32.
Zurück zum Zitat Zambacos GJ, Molnar C, Mandrekas AD. Silicone lymphadenopathy after breast augmentation: case reports, review of the literature, and current thoughts. Aesthet Plast Surg. 2013;37(2):278–89.CrossRef Zambacos GJ, Molnar C, Mandrekas AD. Silicone lymphadenopathy after breast augmentation: case reports, review of the literature, and current thoughts. Aesthet Plast Surg. 2013;37(2):278–89.CrossRef
33.
Zurück zum Zitat Ozkaya N, Grogg KL, Dogan A. Seroma-associated anaplastic large cell lymphoma arising in the background of subcutaneous calcinosis: beyond breast implants. Histopathology. 2016. doi:10.1111/his.13012. Ozkaya N, Grogg KL, Dogan A. Seroma-associated anaplastic large cell lymphoma arising in the background of subcutaneous calcinosis: beyond breast implants. Histopathology. 2016. doi:10.​1111/​his.​13012.​
34.
Zurück zum Zitat Favia G, Tempesta A, Limongelli L, Crincoli V, Piattelli A, Maiorano E. Metastatic breast cancer in medication-related osteonecrosis around mandibular implants. Am J Case Rep. 2015;16:621–6.PubMedPubMedCentralCrossRef Favia G, Tempesta A, Limongelli L, Crincoli V, Piattelli A, Maiorano E. Metastatic breast cancer in medication-related osteonecrosis around mandibular implants. Am J Case Rep. 2015;16:621–6.PubMedPubMedCentralCrossRef
35.
Zurück zum Zitat Bhandari S, Rattan V, Panda N, Vaiphei K, Mittal BR. Oral cancer or periimplantitis: a clinical dilemma. J Prosthet Dent. 2016;115(6):658–61.PubMedCrossRef Bhandari S, Rattan V, Panda N, Vaiphei K, Mittal BR. Oral cancer or periimplantitis: a clinical dilemma. J Prosthet Dent. 2016;115(6):658–61.PubMedCrossRef
36.
Zurück zum Zitat Monsees GM, Kraft P, Hankinson SE, Hunter DJ, Schernhammer ES. Circadian genes and breast cancer susceptibility in rotating shift workers. Int J Cancer. 2012;131(11):2547–52.PubMedPubMedCentralCrossRef Monsees GM, Kraft P, Hankinson SE, Hunter DJ, Schernhammer ES. Circadian genes and breast cancer susceptibility in rotating shift workers. Int J Cancer. 2012;131(11):2547–52.PubMedPubMedCentralCrossRef
37.
Zurück zum Zitat Rafnsson V, Tulinius H, Jónasson JG, Hrafnkelsson J. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control. 2001;12(2):95–101.PubMedCrossRef Rafnsson V, Tulinius H, Jónasson JG, Hrafnkelsson J. Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control. 2001;12(2):95–101.PubMedCrossRef
38.
Zurück zum Zitat Schubauer-Berigan MK, Anderson JL, Hein MJ, Little MP, Sigurdson AJ, Pinkerton LE. Breast cancer incidence in a cohort of U.S. flight attendants. Am J Ind Med. 2015;58(3):252–66.PubMedPubMedCentralCrossRef Schubauer-Berigan MK, Anderson JL, Hein MJ, Little MP, Sigurdson AJ, Pinkerton LE. Breast cancer incidence in a cohort of U.S. flight attendants. Am J Ind Med. 2015;58(3):252–66.PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Pudrovska T, Carr D, McFarland M, Collins C. Higher-status occupations and breast cancer: a life-course stress approach. Soc Sci Med 1982. 2013;89:53–61. Pudrovska T, Carr D, McFarland M, Collins C. Higher-status occupations and breast cancer: a life-course stress approach. Soc Sci Med 1982. 2013;89:53–61.
40.
Zurück zum Zitat Härmä M, Kecklund G. Shift work and health—how to proceed? Scand J Work Environ Health. 2010;36(2):81–4.PubMedCrossRef Härmä M, Kecklund G. Shift work and health—how to proceed? Scand J Work Environ Health. 2010;36(2):81–4.PubMedCrossRef
41.
Zurück zum Zitat Wang X-S, Armstrong MEG, Cairns BJ, Key TJ, Travis RC. Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond). 2011;61(2):78–89.CrossRef Wang X-S, Armstrong MEG, Cairns BJ, Key TJ, Travis RC. Shift work and chronic disease: the epidemiological evidence. Occup Med (Lond). 2011;61(2):78–89.CrossRef
42.
Zurück zum Zitat Richter K, Acker J, Kamcev N, Bajraktarov S, Piehl A, Niklewski G. Recommendations for the prevention of breast cancer in shift workers. EPMA J. 2011;2(4):351–6.PubMedPubMedCentralCrossRef Richter K, Acker J, Kamcev N, Bajraktarov S, Piehl A, Niklewski G. Recommendations for the prevention of breast cancer in shift workers. EPMA J. 2011;2(4):351–6.PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Costa G, Haus E, Stevens R. Shift work and cancer—considerations on rationale, mechanisms, and epidemiology. Scand J Work Environ Health. 2010;36(2):163–79.PubMedCrossRef Costa G, Haus E, Stevens R. Shift work and cancer—considerations on rationale, mechanisms, and epidemiology. Scand J Work Environ Health. 2010;36(2):163–79.PubMedCrossRef
44.
Zurück zum Zitat Pijpe A, Slottje P, van Pelt C, Stehmann F, Kromhout H, van Leeuwen FE, et al. The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses. BMC Cancer. 2014;14:47.PubMedPubMedCentralCrossRef Pijpe A, Slottje P, van Pelt C, Stehmann F, Kromhout H, van Leeuwen FE, et al. The Nightingale study: rationale, study design and baseline characteristics of a prospective cohort study on shift work and breast cancer risk among nurses. BMC Cancer. 2014;14:47.PubMedPubMedCentralCrossRef
45.
Zurück zum Zitat Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses’ Health Study. J Natl Cancer Inst. 2001;93(20):1563–8.PubMedCrossRef Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, et al. Rotating night shifts and risk of breast cancer in women participating in the Nurses’ Health Study. J Natl Cancer Inst. 2001;93(20):1563–8.PubMedCrossRef
46.
Zurück zum Zitat Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2005;41(13):2023–32.PubMedCrossRef Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES. Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer. 2005;41(13):2023–32.PubMedCrossRef
47.
Zurück zum Zitat Hansen J. Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark. Cancer Causes Control. 2006;17(4):531–7.PubMedCrossRef Hansen J. Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark. Cancer Causes Control. 2006;17(4):531–7.PubMedCrossRef
48.
Zurück zum Zitat Fritschi L, Glass DC, Heyworth JS, Aronson K, Girschik J, Boyle T, et al. Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses. 2011;77(3):430–6.PubMedCrossRef Fritschi L, Glass DC, Heyworth JS, Aronson K, Girschik J, Boyle T, et al. Hypotheses for mechanisms linking shiftwork and cancer. Med Hypotheses. 2011;77(3):430–6.PubMedCrossRef
49.
Zurück zum Zitat Linnersjö A, Hammar N, Dammström B-G, Johansson M, Eliasch H. Cancer incidence in airline cabin crew: experience from Sweden. Occup Environ Med. 2003;60(11):810–4.PubMedPubMedCentralCrossRef Linnersjö A, Hammar N, Dammström B-G, Johansson M, Eliasch H. Cancer incidence in airline cabin crew: experience from Sweden. Occup Environ Med. 2003;60(11):810–4.PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743–53.PubMed Bower JE, Ganz PA, Desmond KA, Rowland JH, Meyerowitz BE, Belin TR. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol. 2000;18(4):743–53.PubMed
51.
Zurück zum Zitat Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002;38(1):27–43.PubMedCrossRef Servaes P, Verhagen C, Bleijenberg G. Fatigue in cancer patients during and after treatment: prevalence, correlates and interventions. Eur J Cancer. 2002;38(1):27–43.PubMedCrossRef
52.
Zurück zum Zitat Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Nat Cancer Ins Monogr. 2004;(32):40–50. Lawrence DP, Kupelnick B, Miller K, Devine D, Lau J. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Nat Cancer Ins Monogr. 2004;(32):40–50.
55.
Zurück zum Zitat Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer. 2003;97(11):2919–25.PubMedCrossRef Cleeland CS, Bennett GJ, Dantzer R, Dougherty PM, Dunn AJ, Meyers CA, et al. Are the symptoms of cancer and cancer treatment due to a shared biologic mechanism? A cytokine-immunologic model of cancer symptoms. Cancer. 2003;97(11):2919–25.PubMedCrossRef
56.
Zurück zum Zitat Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008;8(11):887–99.PubMedCrossRef Seruga B, Zhang H, Bernstein LJ, Tannock IF. Cytokines and their relationship to the symptoms and outcome of cancer. Nat Rev Cancer. 2008;8(11):887–99.PubMedCrossRef
57.
Zurück zum Zitat Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res. 2009;15(2):425–30.PubMedCrossRef Aggarwal BB, Vijayalekshmi RV, Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short-term friend, long-term foe. Clin Cancer Res. 2009;15(2):425–30.PubMedCrossRef
58.
Zurück zum Zitat Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, et al. Sleep duration and breast cancer: a prospective cohort study. Cancer Res. 2005;65(20):9595–600.PubMedCrossRef Verkasalo PK, Lillberg K, Stevens RG, Hublin C, Partinen M, Koskenvuo M, et al. Sleep duration and breast cancer: a prospective cohort study. Cancer Res. 2005;65(20):9595–600.PubMedCrossRef
59.
Zurück zum Zitat Girschik J, Heyworth J, Fritschi L. Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case-control study. Am J Epidemiol. 2013;177(4):316–27.PubMedCrossRef Girschik J, Heyworth J, Fritschi L. Self-reported sleep duration, sleep quality, and breast cancer risk in a population-based case-control study. Am J Epidemiol. 2013;177(4):316–27.PubMedCrossRef
60.
Zurück zum Zitat Vogtmann E, Levitan EB, Hale L, Shikany JM, Shah NA, Endeshaw Y, et al. Association between sleep and breast cancer incidence among postmenopausal women in the Women’s Health Initiative. Sleep. 2013;36(10):1437–44.PubMedPubMedCentral Vogtmann E, Levitan EB, Hale L, Shikany JM, Shah NA, Endeshaw Y, et al. Association between sleep and breast cancer incidence among postmenopausal women in the Women’s Health Initiative. Sleep. 2013;36(10):1437–44.PubMedPubMedCentral
61.
Zurück zum Zitat Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH. Sleep and quality of life in breast cancer patients. J Pain Symptom Manag. 2002;24(5):471–80.CrossRef Fortner BV, Stepanski EJ, Wang SC, Kasprowicz S, Durrence HH. Sleep and quality of life in breast cancer patients. J Pain Symptom Manag. 2002;24(5):471–80.CrossRef
62.
Zurück zum Zitat Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, et al. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 2006;14(3):201–9.PubMedCrossRef Ancoli-Israel S, Liu L, Marler MR, Parker BA, Jones V, Sadler GR, et al. Fatigue, sleep, and circadian rhythms prior to chemotherapy for breast cancer. Support Care Cancer. 2006;14(3):201–9.PubMedCrossRef
64.
Zurück zum Zitat Cox TR, Rumney RMH, Schoof EM, Perryman L, Høye AM, Agrawal A, et al. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature. 2015;522(7554):106–10.PubMedPubMedCentralCrossRef Cox TR, Rumney RMH, Schoof EM, Perryman L, Høye AM, Agrawal A, et al. The hypoxic cancer secretome induces pre-metastatic bone lesions through lysyl oxidase. Nature. 2015;522(7554):106–10.PubMedPubMedCentralCrossRef
65.
Zurück zum Zitat Golubnitschaja O, Debald M, Kuhn W, Yeghiazaryan K, Bubnov RV, Goncharenko VM, et al. Flammer syndrome and potential formation of pre-metastatic niches: a multi-centred study on phenotyping, patient stratification, prediction and potential prevention of aggressive breast cancer and metastatic disease. EPMA J. 2016;7(Suppl 1):A25. Golubnitschaja O, Debald M, Kuhn W, Yeghiazaryan K, Bubnov RV, Goncharenko VM, et al. Flammer syndrome and potential formation of pre-metastatic niches: a multi-centred study on phenotyping, patient stratification, prediction and potential prevention of aggressive breast cancer and metastatic disease. EPMA J. 2016;7(Suppl 1):A25.
69.
Zurück zum Zitat Yeghiazaryan K, Flammer J, Golubnitschaja O. Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs. EPMA J. 2010;1(2):263–72.PubMedPubMedCentralCrossRef Yeghiazaryan K, Flammer J, Golubnitschaja O. Predictive molecular profiling in blood of healthy vasospastic individuals: clue to targeted prevention as personalised medicine to effective costs. EPMA J. 2010;1(2):263–72.PubMedPubMedCentralCrossRef
70.
Zurück zum Zitat Golubnitschaja O, Yeghiazaryan K, Flammer J. Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible? EPMA J. 2010;1(2):237–44.PubMedPubMedCentralCrossRef Golubnitschaja O, Yeghiazaryan K, Flammer J. Key molecular pathways affected by glaucoma pathology: is predictive diagnosis possible? EPMA J. 2010;1(2):237–44.PubMedPubMedCentralCrossRef
71.
Zurück zum Zitat Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet. 2011;377(9765):557–67.PubMedPubMedCentralCrossRef Finucane MM, Stevens GA, Cowan MJ, Danaei G, Lin JK, Paciorek CJ, et al. National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet. 2011;377(9765):557–67.PubMedPubMedCentralCrossRef
72.
Zurück zum Zitat Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378(9793):815–25.PubMedCrossRef Wang YC, McPherson K, Marsh T, Gortmaker SL, Brown M. Health and economic burden of the projected obesity trends in the USA and the UK. Lancet. 2011;378(9793):815–25.PubMedCrossRef
73.
Zurück zum Zitat Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff Proj Hope. 2009;28(5):w822–31.CrossRef Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff Proj Hope. 2009;28(5):w822–31.CrossRef
74.
Zurück zum Zitat Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis. Int J Cancer. 2009;124(3):698–712.PubMedCrossRef Suzuki R, Orsini N, Saji S, Key TJ, Wolk A. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis. Int J Cancer. 2009;124(3):698–712.PubMedCrossRef
75.
Zurück zum Zitat Chan DSM, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901–14.PubMedPubMedCentralCrossRef Chan DSM, Vieira AR, Aune D, Bandera EV, Greenwood DC, McTiernan A, et al. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Ann Oncol. 2014;25(10):1901–14.PubMedPubMedCentralCrossRef
76.
Zurück zum Zitat Hilakivi-Clarke L, Forsén T, Eriksson JG, Luoto R, Tuomilehto J, Osmond C, et al. Tallness and overweight during childhood have opposing effects on breast cancer risk. Br J Cancer. 2001;85(11):1680–4.PubMedPubMedCentralCrossRef Hilakivi-Clarke L, Forsén T, Eriksson JG, Luoto R, Tuomilehto J, Osmond C, et al. Tallness and overweight during childhood have opposing effects on breast cancer risk. Br J Cancer. 2001;85(11):1680–4.PubMedPubMedCentralCrossRef
77.
Zurück zum Zitat Baer HJ, Tworoger SS, Hankinson SE, Willett WC. Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol. 2010;171(11):1183–94.PubMedPubMedCentralCrossRef Baer HJ, Tworoger SS, Hankinson SE, Willett WC. Body fatness at young ages and risk of breast cancer throughout life. Am J Epidemiol. 2010;171(11):1183–94.PubMedPubMedCentralCrossRef
78.
Zurück zum Zitat Suzuki R, Iwasaki M, Inoue M, Sasazuki S, Sawada N, Yamaji T, et al. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status—the Japan public health center-based prospective study. Int J Cancer. 2011;129(5):1214–24.PubMedCrossRef Suzuki R, Iwasaki M, Inoue M, Sasazuki S, Sawada N, Yamaji T, et al. Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status—the Japan public health center-based prospective study. Int J Cancer. 2011;129(5):1214–24.PubMedCrossRef
79.
Zurück zum Zitat Robinson WR, Tse CK, Olshan AF, Troester MA. Body size across the life course and risk of premenopausal and postmenopausal breast cancer in black women, the Carolina Breast Cancer Study, 1993-2001. Cancer Causes Control. 2014;25(9):1101–17.PubMedPubMedCentralCrossRef Robinson WR, Tse CK, Olshan AF, Troester MA. Body size across the life course and risk of premenopausal and postmenopausal breast cancer in black women, the Carolina Breast Cancer Study, 1993-2001. Cancer Causes Control. 2014;25(9):1101–17.PubMedPubMedCentralCrossRef
80.
Zurück zum Zitat Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev. 2014;36:114–36.PubMedPubMedCentralCrossRef Munsell MF, Sprague BL, Berry DA, Chisholm G, Trentham-Dietz A. Body mass index and breast cancer risk according to postmenopausal estrogen-progestin use and hormone receptor status. Epidemiol Rev. 2014;36:114–36.PubMedPubMedCentralCrossRef
81.
Zurück zum Zitat Cebioglu M, Schild HH, Golubnitschaja O. Diabetes mellitus as a risk factor for cancer: is predictive diagnosis possible? In: Golubnitschaja O, editor. Predictive diagnostics and personalized treatment: dream or reality? New York: Nova Science Publishers Inc; 2009. p. 247–62. Cebioglu M, Schild HH, Golubnitschaja O. Diabetes mellitus as a risk factor for cancer: is predictive diagnosis possible? In: Golubnitschaja O, editor. Predictive diagnostics and personalized treatment: dream or reality? New York: Nova Science Publishers Inc; 2009. p. 247–62.
82.
Zurück zum Zitat Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K, et al. Diabetes and breast cancer risk: a meta-analysis. Br J Cancer. 2012;107(9):1608–17.PubMedPubMedCentralCrossRef Boyle P, Boniol M, Koechlin A, Robertson C, Valentini F, Coppens K, et al. Diabetes and breast cancer risk: a meta-analysis. Br J Cancer. 2012;107(9):1608–17.PubMedPubMedCentralCrossRef
83.
Zurück zum Zitat Wu AH, Kurian AW, Kwan ML, John EM, Lu Y, Keegan THM, et al. Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomark Prev. 2015;24(2):361–8.CrossRef Wu AH, Kurian AW, Kwan ML, John EM, Lu Y, Keegan THM, et al. Diabetes and other comorbidities in breast cancer survival by race/ethnicity: the California Breast Cancer Survivorship Consortium (CBCSC). Cancer Epidemiol Biomark Prev. 2015;24(2):361–8.CrossRef
84.
Zurück zum Zitat Bodai BI, Tuso P. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J. 2015;19(2):48–79.PubMedPubMedCentralCrossRef Bodai BI, Tuso P. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J. 2015;19(2):48–79.PubMedPubMedCentralCrossRef
85.
Zurück zum Zitat Pronk NP, Anderson LH, Crain AL, Martinson BC, O’Connor PJ, Sherwood NE, et al. Meeting recommendations for multiple healthy lifestyle factors. Prevalence, clustering, and predictors among adolescent, adult, and senior health plan members. Am J Prev Med. 2004;27(2 Suppl):25–33.PubMedCrossRef Pronk NP, Anderson LH, Crain AL, Martinson BC, O’Connor PJ, Sherwood NE, et al. Meeting recommendations for multiple healthy lifestyle factors. Prevalence, clustering, and predictors among adolescent, adult, and senior health plan members. Am J Prev Med. 2004;27(2 Suppl):25–33.PubMedCrossRef
86.
Zurück zum Zitat Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst. 2009;101(6):384–98.PubMedPubMedCentralCrossRef Cummings SR, Tice JA, Bauer S, Browner WS, Cuzick J, Ziv E, et al. Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk. J Natl Cancer Inst. 2009;101(6):384–98.PubMedPubMedCentralCrossRef
87.
Zurück zum Zitat Thompson A, Brennan K, Cox A, Gee J, Harcourt D, Harris A, et al. Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Res. 2008;10(2):R26.PubMedPubMedCentralCrossRef Thompson A, Brennan K, Cox A, Gee J, Harcourt D, Harris A, et al. Evaluation of the current knowledge limitations in breast cancer research: a gap analysis. Breast Cancer Res. 2008;10(2):R26.PubMedPubMedCentralCrossRef
88.
Zurück zum Zitat Janz KF, Dawson JD, Mahoney LT. Tracking physical fitness and physical activity from childhood to adolescence: the muscatine study. Med Sci Sports Exerc. 2000;32(7):1250–7.PubMedCrossRef Janz KF, Dawson JD, Mahoney LT. Tracking physical fitness and physical activity from childhood to adolescence: the muscatine study. Med Sci Sports Exerc. 2000;32(7):1250–7.PubMedCrossRef
89.
Zurück zum Zitat Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens. 1995;8(7):657–65.PubMedCrossRef Bao W, Threefoot SA, Srinivasan SR, Berenson GS. Essential hypertension predicted by tracking of elevated blood pressure from childhood to adulthood: the Bogalusa Heart Study. Am J Hypertens. 1995;8(7):657–65.PubMedCrossRef
90.
Zurück zum Zitat Guo SS, Huang C, Maynard LM, Demerath E, Towne B, Chumlea WC, et al. Body mass index during childhood, adolescence and young adulthood in relation to adult overweight and adiposity: the Fels Longitudinal Study. Int J Obes Relat Metab Disord. 2000;24(12):1628–35.PubMedCrossRef Guo SS, Huang C, Maynard LM, Demerath E, Towne B, Chumlea WC, et al. Body mass index during childhood, adolescence and young adulthood in relation to adult overweight and adiposity: the Fels Longitudinal Study. Int J Obes Relat Metab Disord. 2000;24(12):1628–35.PubMedCrossRef
91.
Zurück zum Zitat Nicklas TA, von Duvillard SP, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to dyslipidemia in adults: the Bogalusa Heart Study. Int J Sports Med. 2002;23(Suppl 1):S39–43.PubMedCrossRef Nicklas TA, von Duvillard SP, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to dyslipidemia in adults: the Bogalusa Heart Study. Int J Sports Med. 2002;23(Suppl 1):S39–43.PubMedCrossRef
92.
Zurück zum Zitat Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases. The role of the cardiovascular specialist. Can J Cardiol. 1999;15(Suppl G):1G–119G. Canadian Cardiovascular Society 1998 Consensus Conference on the Prevention of Cardiovascular Diseases. The role of the cardiovascular specialist. Can J Cardiol. 1999;15(Suppl G):1G–119G.
93.
Zurück zum Zitat Raitakari OT, Porkka KV, Räsänen L, Viikari JS. Relations of life-style with lipids, blood pressure and insulin in adolescents and young adults. The Cardiovascular Risk in Young Finns Study. Atherosclerosis. 1994;111(2):237–46.PubMedCrossRef Raitakari OT, Porkka KV, Räsänen L, Viikari JS. Relations of life-style with lipids, blood pressure and insulin in adolescents and young adults. The Cardiovascular Risk in Young Finns Study. Atherosclerosis. 1994;111(2):237–46.PubMedCrossRef
94.
Zurück zum Zitat Bergström E, Hernell O, Persson LA. Cardiovascular risk indicators cluster in girls from families of low socio-economic status. Acta Paediatr Oslo Nor 1992. 1996;85(9):1083–90. Bergström E, Hernell O, Persson LA. Cardiovascular risk indicators cluster in girls from families of low socio-economic status. Acta Paediatr Oslo Nor 1992. 1996;85(9):1083–90.
95.
Zurück zum Zitat Pate RR, Heath GW, Dowda M, Trost SG. Associations between physical activity and other health behaviors in a representative sample of US adolescents. Am J Public Health. 1996;86(11):1577–81.PubMedPubMedCentralCrossRef Pate RR, Heath GW, Dowda M, Trost SG. Associations between physical activity and other health behaviors in a representative sample of US adolescents. Am J Public Health. 1996;86(11):1577–81.PubMedPubMedCentralCrossRef
96.
Zurück zum Zitat McKenna M, Taylor W, Marks J, Koplan J. Current issues and challenges in chronic disease control. In: Brownson R, Remington P, Davis J, editors. Chronic disease epidemiology and control. Washington DC: United Book; 1998. McKenna M, Taylor W, Marks J, Koplan J. Current issues and challenges in chronic disease control. In: Brownson R, Remington P, Davis J, editors. Chronic disease epidemiology and control. Washington DC: United Book; 1998.
97.
Zurück zum Zitat Golubnitschaja O. Changing long-held beliefs is never easy: a proposal for multimodal approaches in female healthcare—an integrative view. In: Costigliola V, editor. Healthcare overview: new perspectives. vol. 1. Dordrecht: Springer; 2012. p. 251–68. Golubnitschaja O. Changing long-held beliefs is never easy: a proposal for multimodal approaches in female healthcare—an integrative view. In: Costigliola V, editor. Healthcare overview: new perspectives. vol. 1. Dordrecht: Springer; 2012. p. 251–68.
99.
Zurück zum Zitat Eleftheriadou A, Chalastras T, Ferekidou E, Yiotakis I, Kyriou L, Tzagarakis M, et al. Association between squamous cell carcinoma of the head and neck and serum folate and homocysteine. Anticancer Res. 2006;26(3B):2345–8.PubMed Eleftheriadou A, Chalastras T, Ferekidou E, Yiotakis I, Kyriou L, Tzagarakis M, et al. Association between squamous cell carcinoma of the head and neck and serum folate and homocysteine. Anticancer Res. 2006;26(3B):2345–8.PubMed
101.
Zurück zum Zitat Keshteli AH, Baracos VE, Madsen KL. Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review. World J Gastroenterol. 2015;21(4):1081–90.PubMedPubMedCentralCrossRef Keshteli AH, Baracos VE, Madsen KL. Hyperhomocysteinemia as a potential contributor of colorectal cancer development in inflammatory bowel diseases: a review. World J Gastroenterol. 2015;21(4):1081–90.PubMedPubMedCentralCrossRef
102.
Zurück zum Zitat Essouma M, Noubiap JJN. Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. Biomark Res. 2015;3:24.PubMedPubMedCentralCrossRef Essouma M, Noubiap JJN. Therapeutic potential of folic acid supplementation for cardiovascular disease prevention through homocysteine lowering and blockade in rheumatoid arthritis patients. Biomark Res. 2015;3:24.PubMedPubMedCentralCrossRef
103.
Zurück zum Zitat Kamat PK, Kalani A, Givvimani S, Sathnur PB, Tyagi SC, Tyagi N. Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-administered homocysteine in mice. Neuroscience. 2013;252:302–19.PubMedPubMedCentralCrossRef Kamat PK, Kalani A, Givvimani S, Sathnur PB, Tyagi SC, Tyagi N. Hydrogen sulfide attenuates neurodegeneration and neurovascular dysfunction induced by intracerebral-administered homocysteine in mice. Neuroscience. 2013;252:302–19.PubMedPubMedCentralCrossRef
105.
Zurück zum Zitat Kedzierska M, Malinowska J, Glowacki R, Olas B, Bald E, Jeziorski A, et al. The elevated homocysteine stimulates changes of haemostatic function of plasma isolated from breast cancer patients. Mol Cell Biochem. 2011;355(1–2):193–9.PubMedCrossRef Kedzierska M, Malinowska J, Glowacki R, Olas B, Bald E, Jeziorski A, et al. The elevated homocysteine stimulates changes of haemostatic function of plasma isolated from breast cancer patients. Mol Cell Biochem. 2011;355(1–2):193–9.PubMedCrossRef
106.
Zurück zum Zitat Lin J, Lee I-M, Song Y, Cook NR, Selhub J, Manson JE, et al. Plasma homocysteine and cysteine and risk of breast cancer in women. Cancer Res. 2010;70(6):2397–405.PubMedPubMedCentralCrossRef Lin J, Lee I-M, Song Y, Cook NR, Selhub J, Manson JE, et al. Plasma homocysteine and cysteine and risk of breast cancer in women. Cancer Res. 2010;70(6):2397–405.PubMedPubMedCentralCrossRef
107.
Zurück zum Zitat Wu X, Zou T, Cao N, Ni J, Xu W, Zhou T, et al. Plasma homocysteine levels and genetic polymorphisms in folate metablism are associated with breast cancer risk in Chinese women. Hered Cancer Clin Pract. 2014;12(1):2.PubMedPubMedCentralCrossRef Wu X, Zou T, Cao N, Ni J, Xu W, Zhou T, et al. Plasma homocysteine levels and genetic polymorphisms in folate metablism are associated with breast cancer risk in Chinese women. Hered Cancer Clin Pract. 2014;12(1):2.PubMedPubMedCentralCrossRef
108.
Zurück zum Zitat Cho HJ, Lavretsky H, Olmstead R, Levin MJ, Oxman MN, Irwin MR. Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study. Am J Psychiatry. 2008;165(12):1543–50.PubMedPubMedCentralCrossRef Cho HJ, Lavretsky H, Olmstead R, Levin MJ, Oxman MN, Irwin MR. Sleep disturbance and depression recurrence in community-dwelling older adults: a prospective study. Am J Psychiatry. 2008;165(12):1543–50.PubMedPubMedCentralCrossRef
109.
Zurück zum Zitat Cho HJ, Lavretsky H, Olmstead R, Levin M, Oxman MN, Irwin MR. Prior depression history and deterioration of physical health in community-dwelling older adults—a prospective cohort study. Am J Geriatr Psychiatry. 2010;18(5):442–51.PubMedPubMedCentralCrossRef Cho HJ, Lavretsky H, Olmstead R, Levin M, Oxman MN, Irwin MR. Prior depression history and deterioration of physical health in community-dwelling older adults—a prospective cohort study. Am J Geriatr Psychiatry. 2010;18(5):442–51.PubMedPubMedCentralCrossRef
110.
Zurück zum Zitat Monroe SM, Harkness KL. Life stress, the ‘kindling’ hypothesis, and the recurrence of depression: considerations from a life stress perspective. Psychol Rev. 2005;112(2):417–45.PubMedCrossRef Monroe SM, Harkness KL. Life stress, the ‘kindling’ hypothesis, and the recurrence of depression: considerations from a life stress perspective. Psychol Rev. 2005;112(2):417–45.PubMedCrossRef
111.
Zurück zum Zitat Jim HSL, Small BJ, Minton S, Andrykowski M, Jacobsen PB. History of major depressive disorder prospectively predicts worse quality of life in women with breast cancer. Ann Behav Med. 2012;43(3):402–8.PubMedPubMedCentralCrossRef Jim HSL, Small BJ, Minton S, Andrykowski M, Jacobsen PB. History of major depressive disorder prospectively predicts worse quality of life in women with breast cancer. Ann Behav Med. 2012;43(3):402–8.PubMedPubMedCentralCrossRef
112.
Zurück zum Zitat Irwin MR, Olmstead RE, Ganz PA, Haque R. Sleep disturbance, inflammation and depression risk in cancer survivors. Brain Behav Immun. 2013;30(Suppl):S58–67.PubMedCrossRef Irwin MR, Olmstead RE, Ganz PA, Haque R. Sleep disturbance, inflammation and depression risk in cancer survivors. Brain Behav Immun. 2013;30(Suppl):S58–67.PubMedCrossRef
113.
Zurück zum Zitat Giese-Davis J, Wilhelm FH, Conrad A, Abercrombie HC, Sephton S, Yutsis M, et al. Depression and stress reactivity in metastatic breast cancer. Psychosom Med. 2006;68(5):675–83.PubMedCrossRef Giese-Davis J, Wilhelm FH, Conrad A, Abercrombie HC, Sephton S, Yutsis M, et al. Depression and stress reactivity in metastatic breast cancer. Psychosom Med. 2006;68(5):675–83.PubMedCrossRef
114.
Zurück zum Zitat Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry. 2001;158(8):1252–7.PubMedCrossRef Musselman DL, Miller AH, Porter MR, Manatunga A, Gao F, Penna S, et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings. Am J Psychiatry. 2001;158(8):1252–7.PubMedCrossRef
115.
Zurück zum Zitat Jacobsen PB, Donovan KA, Weitzner MA. Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsych. 2003;8(4):229–40. Jacobsen PB, Donovan KA, Weitzner MA. Distinguishing fatigue and depression in patients with cancer. Semin Clin Neuropsych. 2003;8(4):229–40.
116.
Zurück zum Zitat Berkey CS, Willett WC, Frazier AL, Rosner B, Tamimi RM, Rockett HRH, et al. Prospective study of adolescent alcohol consumption and risk of benign breast disease in young women. Pediatrics. 2010;125(5):e1081–7.PubMedPubMedCentralCrossRef Berkey CS, Willett WC, Frazier AL, Rosner B, Tamimi RM, Rockett HRH, et al. Prospective study of adolescent alcohol consumption and risk of benign breast disease in young women. Pediatrics. 2010;125(5):e1081–7.PubMedPubMedCentralCrossRef
117.
Zurück zum Zitat Berkey CS, Tamimi RM, Rosner B, Frazier AL, Colditz GA. Young women with family history of breast cancer and their risk factors for benign breast disease. Cancer. 2012;118(11):2796–803.PubMedCrossRef Berkey CS, Tamimi RM, Rosner B, Frazier AL, Colditz GA. Young women with family history of breast cancer and their risk factors for benign breast disease. Cancer. 2012;118(11):2796–803.PubMedCrossRef
118.
Zurück zum Zitat Ferrari P, Licaj I, Muller DC, Kragh Andersen P, Johansson M, Boeing H, et al. Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. BMJ Open. 2014;4(7):e005245.PubMedPubMedCentralCrossRef Ferrari P, Licaj I, Muller DC, Kragh Andersen P, Johansson M, Boeing H, et al. Lifetime alcohol use and overall and cause-specific mortality in the European Prospective Investigation into Cancer and Nutrition (EPIC) study. BMJ Open. 2014;4(7):e005245.PubMedPubMedCentralCrossRef
119.
Zurück zum Zitat Mathes RW, Malone KE, Daling JR, Davis S, Lucas SM, Porter PL, et al. Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomark Prev. 2008;17(11):3116–22.CrossRef Mathes RW, Malone KE, Daling JR, Davis S, Lucas SM, Porter PL, et al. Migraine in postmenopausal women and the risk of invasive breast cancer. Cancer Epidemiol Biomark Prev. 2008;17(11):3116–22.CrossRef
120.
Zurück zum Zitat Li CI, Mathes RW, Malone KE, Daling JR, Bernstein L, Marchbanks PA, et al. Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer Epidemiol Biomark Prev. 2009;18(7):2030–4.CrossRef Li CI, Mathes RW, Malone KE, Daling JR, Bernstein L, Marchbanks PA, et al. Relationship between migraine history and breast cancer risk among premenopausal and postmenopausal women. Cancer Epidemiol Biomark Prev. 2009;18(7):2030–4.CrossRef
121.
Zurück zum Zitat Li CI, Mathes RW, Bluhm EC, Caan B, Cavanagh MF, Chlebowski RT, et al. Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol. 2010;28(6):1005–10.PubMedPubMedCentralCrossRef Li CI, Mathes RW, Bluhm EC, Caan B, Cavanagh MF, Chlebowski RT, et al. Migraine history and breast cancer risk among postmenopausal women. J Clin Oncol. 2010;28(6):1005–10.PubMedPubMedCentralCrossRef
122.
Zurück zum Zitat Winter AC, Rexrode KM, Lee I-M, Buring JE, Tamimi RM, Kurth T. Migraine and subsequent risk of breast cancer: a prospective cohort study. Cancer Causes Control. 2013;24(1):81–9.PubMedCrossRef Winter AC, Rexrode KM, Lee I-M, Buring JE, Tamimi RM, Kurth T. Migraine and subsequent risk of breast cancer: a prospective cohort study. Cancer Causes Control. 2013;24(1):81–9.PubMedCrossRef
123.
Zurück zum Zitat Esquivel-Velázquez M, Ostoa-Saloma P, Palacios-Arreola MI, Nava-Castro KE, Castro JI, Morales-Montor J. The role of cytokines in breast cancer development and progression. J Interf Cytokine Res. 2015;35(1):1–16.CrossRef Esquivel-Velázquez M, Ostoa-Saloma P, Palacios-Arreola MI, Nava-Castro KE, Castro JI, Morales-Montor J. The role of cytokines in breast cancer development and progression. J Interf Cytokine Res. 2015;35(1):1–16.CrossRef
124.
Zurück zum Zitat McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15(6):1159–69.CrossRef McCormack VA, dos Santos Silva I. Breast density and parenchymal patterns as markers of breast cancer risk: a meta-analysis. Cancer Epidemiol Biomark Prev. 2006;15(6):1159–69.CrossRef
125.
Zurück zum Zitat Meng X, Zhong J, Liu S, Murray M, Gonzalez-Angulo AM. A new hypothesis for the cancer mechanism. Cancer Metastasis Rev. 2012;31(1–2):247–68.PubMedCrossRef Meng X, Zhong J, Liu S, Murray M, Gonzalez-Angulo AM. A new hypothesis for the cancer mechanism. Cancer Metastasis Rev. 2012;31(1–2):247–68.PubMedCrossRef
126.
Zurück zum Zitat Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55(11):2698–708.PubMedCrossRef Page DL, Dupont WD, Rogers LW, Rados MS. Atypical hyperplastic lesions of the female breast. A long-term follow-up study. Cancer. 1985;55(11):2698–708.PubMedCrossRef
127.
Zurück zum Zitat Dupont WD, DL P. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312(3):146–51.PubMedCrossRef Dupont WD, DL P. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med. 1985;312(3):146–51.PubMedCrossRef
128.
129.
Zurück zum Zitat Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71(4):1258–65.PubMedCrossRef Dupont WD, Parl FF, Hartmann WH, Brinton LA, Winfield AC, Worrell JA, et al. Breast cancer risk associated with proliferative breast disease and atypical hyperplasia. Cancer. 1993;71(4):1258–65.PubMedCrossRef
130.
Zurück zum Zitat Collins LC, Achacoso NA, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, et al. Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol. 2007;20(11):1149–55.PubMedCrossRef Collins LC, Achacoso NA, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, et al. Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol. 2007;20(11):1149–55.PubMedCrossRef
131.
Zurück zum Zitat Colditz GA, Bohlke K, Berkey CS. Breast cancer risk accumulation starts early: prevention must also. Breast Cancer Res Treat. 2014;145(3):567–79.PubMedPubMedCentralCrossRef Colditz GA, Bohlke K, Berkey CS. Breast cancer risk accumulation starts early: prevention must also. Breast Cancer Res Treat. 2014;145(3):567–79.PubMedPubMedCentralCrossRef
132.
Zurück zum Zitat Liu Y, Tamimi RM, Berkey CS, Willett WC, Collins LC, Schnitt SJ, et al. Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. Pediatrics. 2012;129(5):e1192–8.PubMedPubMedCentralCrossRef Liu Y, Tamimi RM, Berkey CS, Willett WC, Collins LC, Schnitt SJ, et al. Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. Pediatrics. 2012;129(5):e1192–8.PubMedPubMedCentralCrossRef
133.
Zurück zum Zitat Baer HJ, Schnitt SJ, Connolly JL, Byrne C, Willett WC, Rosner B, et al. Early life factors and incidence of proliferative benign breast disease. Cancer Epidemiol Biomark Prev. 2005;14(12):2889–97.CrossRef Baer HJ, Schnitt SJ, Connolly JL, Byrne C, Willett WC, Rosner B, et al. Early life factors and incidence of proliferative benign breast disease. Cancer Epidemiol Biomark Prev. 2005;14(12):2889–97.CrossRef
134.
Zurück zum Zitat Beaber EF, Malone KE, Tang M-TC, Barlow WE, Porter PL, Daling JR, et al. Oral contraceptives and breast cancer risk overall and by molecular subtype among young women. Cancer Epidemiol Biomark Prev. 2014;23(5):755–64.CrossRef Beaber EF, Malone KE, Tang M-TC, Barlow WE, Porter PL, Daling JR, et al. Oral contraceptives and breast cancer risk overall and by molecular subtype among young women. Cancer Epidemiol Biomark Prev. 2014;23(5):755–64.CrossRef
135.
Zurück zum Zitat Tsai SA, Stefanick ML, Stafford RS. Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009. Menopause. 2011;18(4):385–92.PubMedPubMedCentralCrossRef Tsai SA, Stefanick ML, Stafford RS. Trends in menopausal hormone therapy use of US office-based physicians, 2000-2009. Menopause. 2011;18(4):385–92.PubMedPubMedCentralCrossRef
136.
Zurück zum Zitat Narod SA. Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol. 2011;8(11):669–76.PubMedCrossRef Narod SA. Hormone replacement therapy and the risk of breast cancer. Nat Rev Clin Oncol. 2011;8(11):669–76.PubMedCrossRef
137.
138.
Zurück zum Zitat Bakken K, Fournier A, Lund E, Waaseth M, Dumeaux V, Clavel-Chapelon F, et al. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011;128(1):144–56.PubMedCrossRef Bakken K, Fournier A, Lund E, Waaseth M, Dumeaux V, Clavel-Chapelon F, et al. Menopausal hormone therapy and breast cancer risk: impact of different treatments. The European Prospective Investigation into Cancer and Nutrition. Int J Cancer. 2011;128(1):144–56.PubMedCrossRef
139.
Zurück zum Zitat Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, et al. Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer. 2008;123(4):933–41.PubMedCrossRef Flesch-Janys D, Slanger T, Mutschelknauss E, Kropp S, Obi N, Vettorazzi E, et al. Risk of different histological types of postmenopausal breast cancer by type and regimen of menopausal hormone therapy. Int J Cancer. 2008;123(4):933–41.PubMedCrossRef
140.
Zurück zum Zitat Rudolph A, Hein R, Lindström S, Beckmann L, Behrens S, Liu J, et al. Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. Endocr Relat Cancer. 2013;20(6):875–87.PubMedPubMedCentralCrossRef Rudolph A, Hein R, Lindström S, Beckmann L, Behrens S, Liu J, et al. Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. Endocr Relat Cancer. 2013;20(6):875–87.PubMedPubMedCentralCrossRef
141.
Zurück zum Zitat Berrington de González A. Estimates of the potential risk of radiation-related cancer from screening in the UK. J Med Screen. 2011;18(4):163–4.PubMedPubMedCentralCrossRef Berrington de González A. Estimates of the potential risk of radiation-related cancer from screening in the UK. J Med Screen. 2011;18(4):163–4.PubMedPubMedCentralCrossRef
142.
Zurück zum Zitat Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(10):727–37 .W237-242PubMedPubMedCentralCrossRef Nelson HD, Tyne K, Naik A, Bougatsos C, Chan BK, Humphrey L, et al. Screening for breast cancer: an update for the U.S. Preventive Services Task Force. Ann Intern Med. 2009;151(10):727–37 .W237-242PubMedPubMedCentralCrossRef
143.
Zurück zum Zitat Zhang XH-F, Giuliano M, Trivedi MV, Schiff R, Osborne CK. Metastasis dormancy in estrogen receptor-positive breast cancer. Clin Cancer Res. 2013;19(23):6389–97.PubMedCrossRef Zhang XH-F, Giuliano M, Trivedi MV, Schiff R, Osborne CK. Metastasis dormancy in estrogen receptor-positive breast cancer. Clin Cancer Res. 2013;19(23):6389–97.PubMedCrossRef
144.
Zurück zum Zitat Debald M, Yeghiazaryan K, Cebioglu M, Kuhn W, Schild HH, Golubnitschaja O. ‘Suspect molecular signature’ in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention. EPMA J. 2013;4(1):22.PubMedPubMedCentralCrossRef Debald M, Yeghiazaryan K, Cebioglu M, Kuhn W, Schild HH, Golubnitschaja O. ‘Suspect molecular signature’ in blood as the indicator of undiagnosed breast cancer, cancer risk and targeted prevention. EPMA J. 2013;4(1):22.PubMedPubMedCentralCrossRef
145.
Zurück zum Zitat Christodoulatos GS, Dalamaga M. Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: quo vadis? World J Clin Oncol. 2014;5(2):71–81.PubMedPubMedCentralCrossRef Christodoulatos GS, Dalamaga M. Micro-RNAs as clinical biomarkers and therapeutic targets in breast cancer: quo vadis? World J Clin Oncol. 2014;5(2):71–81.PubMedPubMedCentralCrossRef
146.
Zurück zum Zitat Kloten V, Becker B, Winner K, Schrauder MG, Fasching PA, Anzeneder T, et al. Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening. Breast Cancer Res. 2013;15(1):R4.PubMedPubMedCentralCrossRef Kloten V, Becker B, Winner K, Schrauder MG, Fasching PA, Anzeneder T, et al. Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening. Breast Cancer Res. 2013;15(1):R4.PubMedPubMedCentralCrossRef
147.
Zurück zum Zitat Hayashi T, Asano H, Toyooka S, Tsukuda K, Soh J, Shien T, et al. DNA methylation status of REIC/Dkk-3 gene in human malignancies. J Cancer Res Clin Oncol. 2012;138(5):799–809.PubMedPubMedCentralCrossRef Hayashi T, Asano H, Toyooka S, Tsukuda K, Soh J, Shien T, et al. DNA methylation status of REIC/Dkk-3 gene in human malignancies. J Cancer Res Clin Oncol. 2012;138(5):799–809.PubMedPubMedCentralCrossRef
148.
Zurück zum Zitat Fujikane T, Nishikawa N, Toyota M, Suzuki H, Nojima M, Maruyama R, et al. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer. Breast Cancer Res Treat. 2010;122(3):699–710.PubMedCrossRef Fujikane T, Nishikawa N, Toyota M, Suzuki H, Nojima M, Maruyama R, et al. Genomic screening for genes upregulated by demethylation revealed novel targets of epigenetic silencing in breast cancer. Breast Cancer Res Treat. 2010;122(3):699–710.PubMedCrossRef
149.
Zurück zum Zitat Stötzer OJ, Lehner J, Fersching-Gierlich D, Nagel D, Holdenrieder S. Diagnostic relevance of plasma DNA and DNA integrity for breast cancer. Tumour Biol. 2014;35(2):1183–91.PubMedCrossRef Stötzer OJ, Lehner J, Fersching-Gierlich D, Nagel D, Holdenrieder S. Diagnostic relevance of plasma DNA and DNA integrity for breast cancer. Tumour Biol. 2014;35(2):1183–91.PubMedCrossRef
150.
Zurück zum Zitat Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, et al. Circulating MMP2 and MMP9 in breast cancer—potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer. 2006;119(6):1403–11.PubMedCrossRef Somiari SB, Somiari RI, Heckman CM, Olsen CH, Jordan RM, Russell SJ, et al. Circulating MMP2 and MMP9 in breast cancer—potential role in classification of patients into low risk, high risk, benign disease and breast cancer categories. Int J Cancer. 2006;119(6):1403–11.PubMedCrossRef
151.
Zurück zum Zitat Somiari SB, Shriver CD, Heckman C, Olsen C, Hu H, Jordan R, et al. Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett. 2006;233(1):98–107.PubMedCrossRef Somiari SB, Shriver CD, Heckman C, Olsen C, Hu H, Jordan R, et al. Plasma concentration and activity of matrix metalloproteinase 2 and 9 in patients with breast disease, breast cancer and at risk of developing breast cancer. Cancer Lett. 2006;233(1):98–107.PubMedCrossRef
152.
Zurück zum Zitat Slattery ML, John E, Torres-Mejia G, Stern M, Lundgreen A, Hines L, et al. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PLoS One. 2013;8(5):e63165.PubMedPubMedCentralCrossRef Slattery ML, John E, Torres-Mejia G, Stern M, Lundgreen A, Hines L, et al. Matrix metalloproteinase genes are associated with breast cancer risk and survival: the Breast Cancer Health Disparities Study. PLoS One. 2013;8(5):e63165.PubMedPubMedCentralCrossRef
153.
Zurück zum Zitat Slattery ML, John EM, Stern MC, Herrick J, Lundgreen A, Giuliano AR, et al. Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study. Breast Cancer Res Treat. 2013;140(3):587–601.PubMedPubMedCentralCrossRef Slattery ML, John EM, Stern MC, Herrick J, Lundgreen A, Giuliano AR, et al. Associations with growth factor genes (FGF1, FGF2, PDGFB, FGFR2, NRG2, EGF, ERBB2) with breast cancer risk and survival: the Breast Cancer Health Disparities Study. Breast Cancer Res Treat. 2013;140(3):587–601.PubMedPubMedCentralCrossRef
154.
Zurück zum Zitat Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Lewinger JP, Stern MC, et al. Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study. Int J Cancer. 2014;134(3):629–44.PubMedCrossRef Slattery ML, John EM, Torres-Mejia G, Lundgreen A, Lewinger JP, Stern MC, et al. Angiogenesis genes, dietary oxidative balance and breast cancer risk and progression: the Breast Cancer Health Disparities Study. Int J Cancer. 2014;134(3):629–44.PubMedCrossRef
155.
Zurück zum Zitat Resler AJ, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, et al. Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study. BMC Cancer. 2013;13:219.PubMedPubMedCentralCrossRef Resler AJ, Malone KE, Johnson LG, Malkki M, Petersdorf EW, McKnight B, et al. Genetic variation in TLR or NFkappaB pathways and the risk of breast cancer: a case-control study. BMC Cancer. 2013;13:219.PubMedPubMedCentralCrossRef
156.
Zurück zum Zitat Melander O, Belting M, Manjer J, Maisel AS, Hedblad B, Engström G, et al. Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancer. Cancer Epidemiol Biomark Prev. 2014;23(8):1672–6.CrossRef Melander O, Belting M, Manjer J, Maisel AS, Hedblad B, Engström G, et al. Validation of plasma proneurotensin as a novel biomarker for the prediction of incident breast cancer. Cancer Epidemiol Biomark Prev. 2014;23(8):1672–6.CrossRef
157.
Zurück zum Zitat Baer HJ, Brawarsky P, Murray MF, Haas JS. Familial risk of cancer and knowledge and use of genetic testing. J Gen Intern Med. 2010;25(7):717–24.PubMedPubMedCentralCrossRef Baer HJ, Brawarsky P, Murray MF, Haas JS. Familial risk of cancer and knowledge and use of genetic testing. J Gen Intern Med. 2010;25(7):717–24.PubMedPubMedCentralCrossRef
158.
Zurück zum Zitat Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, et al. Reproductive windows, genetic loci, and breast cancer risk. Ann Epidemiol. 2014;24(5):376–82.PubMedPubMedCentralCrossRef Warren Andersen S, Trentham-Dietz A, Gangnon RE, Hampton JM, Figueroa JD, Skinner HG, et al. Reproductive windows, genetic loci, and breast cancer risk. Ann Epidemiol. 2014;24(5):376–82.PubMedPubMedCentralCrossRef
159.
Zurück zum Zitat Elebro K, Butt S, Dorkhan M, Jernström H, Borgquist S. Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort. Cancer Causes Control. 2014;25(8):945–57.PubMedCrossRef Elebro K, Butt S, Dorkhan M, Jernström H, Borgquist S. Age at first childbirth and oral contraceptive use are associated with risk of androgen receptor-negative breast cancer: the Malmö Diet and Cancer Cohort. Cancer Causes Control. 2014;25(8):945–57.PubMedCrossRef
161.
Zurück zum Zitat Anothaisintawee T, Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, et al. Risk factors of breast cancer: a systematic review and meta-analysis. Asia Pac J Public Health. 2013;25(5):368–87.PubMedCrossRef Anothaisintawee T, Wiratkapun C, Lerdsitthichai P, Kasamesup V, Wongwaisayawan S, Srinakarin J, et al. Risk factors of breast cancer: a systematic review and meta-analysis. Asia Pac J Public Health. 2013;25(5):368–87.PubMedCrossRef
162.
Zurück zum Zitat Chlebowski RT. Nutrition and physical activity influence on breast cancer incidence and outcome. Breast. 2013;22(Suppl 2):S30–7.PubMedCrossRef Chlebowski RT. Nutrition and physical activity influence on breast cancer incidence and outcome. Breast. 2013;22(Suppl 2):S30–7.PubMedCrossRef
163.
Zurück zum Zitat Steindorf K, Schmidt M, Ulrich C. Effects of physical activity on cancer risk and disease progression after cancer diagnosis. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2012;55(1):10–6.CrossRef Steindorf K, Schmidt M, Ulrich C. Effects of physical activity on cancer risk and disease progression after cancer diagnosis. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz. 2012;55(1):10–6.CrossRef
165.
Zurück zum Zitat Orlando LA, RR W, Beadles C, Himmel T, Buchanan AH, Powell KP, et al. Implementing family health history risk stratification in primary care: impact of guideline criteria on populations and resource demand. Am J Med Genet C: Semin Med Genet. 2014;166C(1):24–33.CrossRef Orlando LA, RR W, Beadles C, Himmel T, Buchanan AH, Powell KP, et al. Implementing family health history risk stratification in primary care: impact of guideline criteria on populations and resource demand. Am J Med Genet C: Semin Med Genet. 2014;166C(1):24–33.CrossRef
166.
Zurück zum Zitat Xue F, Willett WC, Rosner BA, Hankinson SE, Michels KB. Cigarette smoking and the incidence of breast cancer. Arch Intern Med. 2011;171(2):125–33.PubMedPubMedCentralCrossRef Xue F, Willett WC, Rosner BA, Hankinson SE, Michels KB. Cigarette smoking and the incidence of breast cancer. Arch Intern Med. 2011;171(2):125–33.PubMedPubMedCentralCrossRef
168.
Zurück zum Zitat Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG, et al. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control. 2011;20(1):e2.PubMedCrossRef Johnson KC, Miller AB, Collishaw NE, Palmer JR, Hammond SK, Salmon AG, et al. Active smoking and secondhand smoke increase breast cancer risk: the report of the Canadian Expert Panel on Tobacco Smoke and Breast Cancer Risk (2009). Tob Control. 2011;20(1):e2.PubMedCrossRef
169.
Zurück zum Zitat Truong T, Liquet B, Menegaux F, Plancoulaine S, Laurent-Puig P, Mulot C, et al. Breast cancer risk, nightwork, and circadian clock gene polymorphisms. Endocr Relat Cancer. 2014;21(4):629–38.PubMedCrossRef Truong T, Liquet B, Menegaux F, Plancoulaine S, Laurent-Puig P, Mulot C, et al. Breast cancer risk, nightwork, and circadian clock gene polymorphisms. Endocr Relat Cancer. 2014;21(4):629–38.PubMedCrossRef
170.
Zurück zum Zitat Bracci M, Manzella N, Copertaro A, Staffolani S, Strafella E, Barbaresi M, et al. Rotating-shift nurses after a day off: peripheral clock gene expression, urinary melatonin, and serum 17-β-estradiol levels. Scand J Work Environ Health. 2014;40(3):295–304.PubMedCrossRef Bracci M, Manzella N, Copertaro A, Staffolani S, Strafella E, Barbaresi M, et al. Rotating-shift nurses after a day off: peripheral clock gene expression, urinary melatonin, and serum 17-β-estradiol levels. Scand J Work Environ Health. 2014;40(3):295–304.PubMedCrossRef
171.
Zurück zum Zitat Mao Y, Fu A, Leaderer D, Zheng T, Chen K, Zhu Y. Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses. BMC Cancer. 2013;13:498.PubMedPubMedCentralCrossRef Mao Y, Fu A, Leaderer D, Zheng T, Chen K, Zhu Y. Potential cancer-related role of circadian gene TIMELESS suggested by expression profiling and in vitro analyses. BMC Cancer. 2013;13:498.PubMedPubMedCentralCrossRef
172.
Zurück zum Zitat Kelleher FC, Rao A, Maguire A. Circadian molecular clocks and cancer. Cancer Lett. 2014;342(1):9–18.PubMedCrossRef Kelleher FC, Rao A, Maguire A. Circadian molecular clocks and cancer. Cancer Lett. 2014;342(1):9–18.PubMedCrossRef
173.
174.
Zurück zum Zitat Girschik J, Fritschi L, Erren TC, Heyworth J. Quantitative exposure metrics for sleep disturbance and their association with breast cancer risk. Cancer Causes Control. 2013;24(5):919–28.PubMedCrossRef Girschik J, Fritschi L, Erren TC, Heyworth J. Quantitative exposure metrics for sleep disturbance and their association with breast cancer risk. Cancer Causes Control. 2013;24(5):919–28.PubMedCrossRef
175.
Zurück zum Zitat Malina C, Frigo S, Mathelin C. Sleep and breast cancer: is there a link? Gynécologie Obstétrique Fertil. 2013;41(2):105–9.CrossRef Malina C, Frigo S, Mathelin C. Sleep and breast cancer: is there a link? Gynécologie Obstétrique Fertil. 2013;41(2):105–9.CrossRef
176.
Zurück zum Zitat Schernhammer ES, Hankinson SE. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses’ Health Study cohort. Cancer Epidemiol Biomark Prev. 2009;18(1):74–9.CrossRef Schernhammer ES, Hankinson SE. Urinary melatonin levels and postmenopausal breast cancer risk in the Nurses’ Health Study cohort. Cancer Epidemiol Biomark Prev. 2009;18(1):74–9.CrossRef
177.
Zurück zum Zitat Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, et al. Urinary 6-sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomark Prev. 2010;19(3):729–37.CrossRef Schernhammer ES, Berrino F, Krogh V, Secreto G, Micheli A, Venturelli E, et al. Urinary 6-sulphatoxymelatonin levels and risk of breast cancer in premenopausal women: the ORDET cohort. Cancer Epidemiol Biomark Prev. 2010;19(3):729–37.CrossRef
178.
Zurück zum Zitat Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev. 2013;14(8):665–78.PubMedCrossRef Amadou A, Ferrari P, Muwonge R, Moskal A, Biessy C, Romieu I, et al. Overweight, obesity and risk of premenopausal breast cancer according to ethnicity: a systematic review and dose-response meta-analysis. Obes Rev. 2013;14(8):665–78.PubMedCrossRef
179.
Zurück zum Zitat Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003;95(16):1218–26.PubMedCrossRef Key TJ, Appleby PN, Reeves GK, Roddam A, Dorgan JF, Longcope C, et al. Body mass index, serum sex hormones, and breast cancer risk in postmenopausal women. J Natl Cancer Inst. 2003;95(16):1218–26.PubMedCrossRef
180.
Zurück zum Zitat Gallagher EJ, LeRoith D. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire? Curr Opin Endocrinol Diabetes Obes. 2013;20(5):485–94.PubMedCrossRef Gallagher EJ, LeRoith D. Diabetes, antihyperglycemic medications and cancer risk: smoke or fire? Curr Opin Endocrinol Diabetes Obes. 2013;20(5):485–94.PubMedCrossRef
181.
Zurück zum Zitat Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, Williams GM, et al. Type 2 diabetes mellitus, glycemic control, and cancer risk. Eur J Cancer. 2014;23(2):134–40.CrossRef Onitilo AA, Stankowski RV, Berg RL, Engel JM, Glurich I, Williams GM, et al. Type 2 diabetes mellitus, glycemic control, and cancer risk. Eur J Cancer. 2014;23(2):134–40.CrossRef
182.
Zurück zum Zitat Xu C-X, Zhu H-H, Zhu Y-M. Diabetes and cancer: associations, mechanisms, and implications for medical practice. World J Diabetes. 2014;5(3):372–80.PubMedPubMedCentralCrossRef Xu C-X, Zhu H-H, Zhu Y-M. Diabetes and cancer: associations, mechanisms, and implications for medical practice. World J Diabetes. 2014;5(3):372–80.PubMedPubMedCentralCrossRef
183.
Zurück zum Zitat Naushad SM, Reddy CA, Kumaraswami K, Divyya S, Kotamraju S, Gottumukkala SR, et al. Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective. Cell Biochem Biophys. 2014;68(2):397–406.PubMedCrossRef Naushad SM, Reddy CA, Kumaraswami K, Divyya S, Kotamraju S, Gottumukkala SR, et al. Impact of hyperhomocysteinemia on breast cancer initiation and progression: epigenetic perspective. Cell Biochem Biophys. 2014;68(2):397–406.PubMedCrossRef
184.
Zurück zum Zitat Hansen MV, Madsen MT, Hageman I, Rasmussen LS, Bokmand S, Rosenberg J, et al. The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial. BMJ Open. 2012;2(1):e000647.PubMedPubMedCentralCrossRef Hansen MV, Madsen MT, Hageman I, Rasmussen LS, Bokmand S, Rosenberg J, et al. The effect of MELatOnin on Depression, anxietY, cognitive function and sleep disturbances in patients with breast cancer. The MELODY trial: protocol for a randomised, placebo-controlled, double-blinded trial. BMJ Open. 2012;2(1):e000647.PubMedPubMedCentralCrossRef
185.
Zurück zum Zitat Hrushesky WJM, Grutsch J, Wood P, Yang X, E-Y O, Ansell C, et al. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther. 2009;8(4):387–97.PubMedCrossRef Hrushesky WJM, Grutsch J, Wood P, Yang X, E-Y O, Ansell C, et al. Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther. 2009;8(4):387–97.PubMedCrossRef
186.
Zurück zum Zitat Lemogne C, Consoli SM, Melchior M, Nabi H, Coeuret-Pellicer M, Limosin F, et al. Depression and the risk of cancer: a 15-year follow-up study of the GAZEL cohort. Am J Epidemiol. 2013;178(12):1712–20.PubMedCrossRef Lemogne C, Consoli SM, Melchior M, Nabi H, Coeuret-Pellicer M, Limosin F, et al. Depression and the risk of cancer: a 15-year follow-up study of the GAZEL cohort. Am J Epidemiol. 2013;178(12):1712–20.PubMedCrossRef
187.
Zurück zum Zitat Nakaya N. Effect of psychosocial factors on cancer risk and survival. J Epidemiol Jpn Epidemiol Assoc. 2014;24(1):1–6.CrossRef Nakaya N. Effect of psychosocial factors on cancer risk and survival. J Epidemiol Jpn Epidemiol Assoc. 2014;24(1):1–6.CrossRef
189.
Zurück zum Zitat Lund E, Bakken K, Dumeaux V, Andersen V, Kumle M. Hormone replacement therapy and breast cancer in former users of oral contraceptives—the Norwegian Women and Cancer study. Int J Cancer. 2007;121(3):645–8.PubMedCrossRef Lund E, Bakken K, Dumeaux V, Andersen V, Kumle M. Hormone replacement therapy and breast cancer in former users of oral contraceptives—the Norwegian Women and Cancer study. Int J Cancer. 2007;121(3):645–8.PubMedCrossRef
Metadaten
Titel
Breast cancer epidemic in the early twenty-first century: evaluation of risk factors, cumulative questionnaires and recommendations for preventive measures
verfasst von
Olga Golubnitschaja
Manuel Debald
Kristina Yeghiazaryan
Walther Kuhn
Martin Pešta
Vincenzo Costigliola
Godfrey Grech
Publikationsdatum
22.07.2016
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 10/2016
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-016-5168-x

Weitere Artikel der Ausgabe 10/2016

Tumor Biology 10/2016 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.